High glucose enhances the metastatic potential of tongue squamous cell carcinoma via the PKM2 pathway

被引:13
|
作者
Wang, Wei [1 ]
He, Qianting [1 ]
Yan, Wangxiang [1 ]
Sun, Jingjing [1 ]
Chen, Zujian [2 ]
Liu, Zhonghua [1 ]
Lu, Zhiyuan [1 ]
Hou, Jinsong [3 ]
Shao, Yisen [4 ]
Zhou, Xiaofeng [2 ]
Wang, Anxun [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China
[2] Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Chicago, IL USA
[3] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China
[4] Jiangxi Univ Tradit Chinese Med, Affiliated Hosp, Dept Oral & Maxillofacial Surg, Nanchang, Jiangxi, Peoples R China
关键词
tongue squamous cell carcinoma; metastasis; high glucose; PKM2; PYRUVATE-KINASE M2; DIABETES-MELLITUS; DOWN-REGULATION; CANCER PATIENTS; POOR-PROGNOSIS; INVASION; MIGRATION; DEREGULATION; PROMOTES; TARGET;
D O I
10.18632/oncotarget.22907
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous evidence has indicated an increased cancer risk in individuals with diabetes mellitus (DM). The aim of this study was to investigate the relationship between DM (high glucose) and tongue squamous cell carcinoma (TSCC) and how high glucose mediated the metastatic potential of TSCC. The relationship between DM and TSCC was assessed in a retrospective study. The role and its mechanism of high glucose on the proliferation, metastatic potential of TSCC were investigated in vitro and in vivo. The prevalence rate of DM in patients with TSCC was 12.84%, which was significantly higher than that (9.7%) in the general population in China. Although no significant difference was observed in the overall survival (OS) rate, TSCC patients with DM have a 1.38-fold increase in relative risk affecting 5-year OS compared to patients without DM. High glucose enhanced the TSCC cell proliferation, migration, invasion and upregulated PKM2 (pyruvate kinase M2) expression. Whereas, these effect was abolished after knockdown of PKM2 in TSCC cells. High glucose promoted tumour growth and lung metastasis of TSCC in a DM animal model. Our results confirm DM as a risk factor for the development of TSCC. High glucose enhances the metastatic potential of TSCC through stimulation of the PKM2 pathway.
引用
收藏
页码:111770 / 111779
页数:10
相关论文
共 50 条
  • [21] GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism*
    Zhou, Qiang
    Yin, Yirui
    Yu, Mincheng
    Gao, Dongmei
    Sun, Jialei
    Yang, Zhangfu
    Weng, Jialei
    Chen, Wanyong
    Atyah, Manar
    Shen, Yinghao
    Ye, Qinghai
    Li, Chia -Wei
    Hung, Mien-Chie
    Dong, Qiongzhu
    Zhou, Chenhao
    Ren, Ning
    REDOX BIOLOGY, 2022, 56
  • [22] Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2/STAT3/c-MYC signaling pathway
    Yang, Yi
    Li, Shan
    Shi, Wenjie
    Jin, Guoguo
    Guo, Dandan
    Li, Aifang
    Wang, Baiyan
    Lu, Baoping
    Feng, Shuying
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 142
  • [24] Metastatic tongue squamous cell carcinoma at a percutaneous endoscopic gastrostomy site via introducer technique
    Takaoka, Shohei
    Yanagawa, Toru
    Saito, Hitoaki
    Ishibashi-Kanno, Naomi
    Yamagata, Kenji
    Bukawa, Hiroki
    ORAL SCIENCE INTERNATIONAL, 2025, 22 (01)
  • [25] Modulation of Ovarian Cancer Cell Metabolism via Pyruvate Kinase M2 (PKM2) and Glucose Deprivation
    Justiniano, Jeanine
    Garrity, Ryan
    Gonzalez, Alfredo
    Wan, Yinsheng
    FASEB JOURNAL, 2015, 29
  • [26] A PKM2 inhibitor induces apoptosis and autophagy through JAK2 in human oral squamous cell carcinoma cells
    Weng, Jing-Ru
    Gopula, Balraj
    Chu, Po-Chen
    Hu, Jing-Lan
    Feng, Chia-Hsien
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 380
  • [27] Sanguinarine suppresses oral squamous cell carcinoma progression by targeting the PKM2/TFEB aix to inhibit autophagic flux
    Peng, Yong-Chun
    He, Zhi-Jing
    Yin, Lun-Cai
    Pi, Hui-Feng
    Jiang, Yi
    Li, Ke-Yan
    Tian, Li
    Xie, Jia
    Zhang, Jian-Bo
    Li, Chen-Yao
    Feng, Guan-Ying
    Wang, Kai
    Zhou, Ding-Zhou
    Xie, Xiao-Wei
    Zhang, Zhi-Yuan
    Fan, Teng-Fei
    PHYTOMEDICINE, 2025, 136
  • [28] Delta-Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway
    Liu, Xiangye
    Li, Tingting
    Wang, Yuting
    Gao, Xiaoge
    Wang, Feitong
    Chen, Yang
    Wang, Kaisheng
    Luo, Weiming
    Kong, Fanyun
    Kou, Yanbo
    You, Hongjuan
    Kong, Delong
    Zhang, Qing
    Tang, Renxian
    MOLECULAR CARCINOGENESIS, 2025, 64 (01) : 176 - 191
  • [29] Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target
    Gustav van Niekerk
    Anna-Mart Engelbrecht
    Cellular Oncology, 2018, 41 : 343 - 351
  • [30] Knockdown of PKM2 Enhances Radiosensitivity of Non-small cell Lung Cancer
    Shijiang Wang
    Yan Ma
    Peiguo Wang
    Zheng Song
    Bin Liu
    Xindong Sun
    Huaqi Zhang
    Jinming Yu
    Cell Biochemistry and Biophysics, 2015, 73 : 21 - 26